In this review
A bundled service needs a plan-specific quote
MyStart’s appeal is a single place to arrange a clinical review, continuing contact and pharmacy fulfillment. Its homepage FAQ starts the programme at $299 per month before discounts and lists evaluations, follow-up, prescribed medication, necessary blood work and shipping among the inclusions. That is a starting programme statement, not a complete quote for every medication and supply. [1]
The homepage says there are no membership fees, while the refund policy calls the recurring purchase an all-inclusive membership that supplies support regardless of prescribing. I would establish what the selected payment buys before comparing it with a separate care fee elsewhere. [1] [2]
Compare a different bundled payment structure in our Sprout Health review.
The phone offer does not resolve the price
The public phone landing page displays compounded tirzepatide at $279 against $399. The card does not give a clear billing interval. Its promotion and the homepage’s $299 starting programme statement should not be combined into a new monthly treatment total. [1] [4]
That page also displays Wegovy and Ozempic price cards, then expressly says MyStart does not offer those branded products. The disclaimer matters. I would not shortlist the service for a branded prescription on the strength of those cards, or infer current availability from the dollar figures. [4]
Keep the quoted charge and supply period together in the complete treatment-cost planner.
Renewal and supply run on different clocks
The homepage FAQ distinguishes monthly automatic billing and shipping from three-month automatic billing with the full three-month supply sent together. It also describes a required refill intake every three months. The actual purchase needs the supply period, payment amount and next renewal date together. [1]
The price-lock answer excludes the first-time discount from its base-plan promise. A holiday saving therefore does not establish the renewal charge. The February 2026 terms leave payment details to checkout or enrollment; the generic terms do not fill in a missing plan-specific total. [1] [3]
For a different membership-versus-bundle distinction, read our Zealthy review.
Cancellation is not a universal prescription refund
MyStart says readers can request cancellation at any time through support. The December 2025 refund policy gives a full-refund exception for medical ineligibility when no prescription was written and no medication shipped. It separately allows cancellation before pharmacy fulfillment, but another section denies refunds once a prescription is written. [1] [2]
Those cutoffs need clarification before payment. The policy consistently rejects medication returns and refunds after shipment, and excludes completed or partly completed membership periods. Future cancellation should not be treated as a guarantee that a current pharmacy order or used service period will be refunded. [2]
Compare the full commitment in our provider comparisons.
The preparation and the platform are separate decisions
MyStart identifies itself as a technology platform rather than the treating clinician or dispensing pharmacy. Its disclosures identify compounded preparations as not FDA-approved. A licensed clinician’s decision and the actual dispensing pharmacy remain important even when the commercial package is simple. [1] [6]
FDA’s September 9, 2025 warning addressed advertising that implied compounded semaglutide was the same as approved medicine. That dated letter does not establish later resolution, contamination or an individual clinical outcome. It does explain why a compound should not be presented as an approved generic. [5]
Keep formulation claims separate with the formulation evidence guide.
Choose the care arrangement before the discount
The homepage’s results qualification describes a survey of sixteen customers, with self-reported experiences and outcomes that are not typical. That is not a controlled comparison of this service against another clinical programme. Neither testimonials nor a weight-loss calculator establish what the reader will achieve. [1]
MyStart belongs on a conditional comparison when cash-pay care coordination is useful and the written purchase resolves the outstanding terms. LifeMD is a separate clinical-access alternative with its own fees and medicine scope. Compare the care relationship and continuing cost rather than assuming either service guarantees the same prescription.
For the separate clinical-access comparison, see our LifeMD review.
Compare continuing behavioral and clinical support in our Noom Med review.
For a separate coordinated-care purchase and its longer-plan terms, read our TMates review.
Understanding the cost
Homepage FAQ starts the programme at $299/month before discounts and describes monthly or three-month renewal. Actual selected medicine, supply, promotion and recurring total require a written quote. Separate phone page advertises compounded tirzepatide $279 against $399 without a clear card interval; do not treat that as a monthly complete-care price. Brand-name cards conflict with that page’s express no-Wegovy/no-Ozempic disclosure. Refund cutoff wording conflicts between prescription issuance and fulfillment/shipment. [1] [2] [3] [4]
Build your cost estimateSources
- MyStart: programme pricing, renewals and independent-care disclosures
- MyStart: December 1, 2025 refund and fulfillment policy
- MyStart: February 1, 2026 terms and payment scope
- MyStart: public phone-offer cards and brand-name exclusion
- FDA: September 9, 2025 MyStart advertising warning
- MyStart: compounded-product and results disclosures
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.